Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike Briley

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|May 22, 2002
The green evolution of psychotropic drugsMike Briley, Chantal Moret
Neuropsychiatric Disease and Treatment|July 14, 2011
The importance of norepinephrine in depressionChantal Moret, Mike Briley
Neuropsychiatric Disease and Treatment|July 14, 2011
The noradrenergic symptom cluster: clinical expression and neuropharmacologyPierre Blier, Mike Briley
Human Psychopharmacology|March 3, 2004
Sedation, an unpleasant, undesirable and potentially dangerous side-effect of many psychotropic drugsMichel Bourin, Mike Briley
Neuropsychiatric Disease and Treatment|July 14, 2011
Noradrenergic symptom cluster in depressionStuart Montgomery, Mike Briley
Human Psychopharmacology|May 30, 2009
Fibromyalgia: a complex syndrome requiring a multidisciplinary approachMichael Spaeth, Mike Briley
Human Psychopharmacology|May 30, 2009
Why psychiatrists should not ignore pain in their patients--focus on fibromyalgia?Stephen M Stahl, Mike Briley
Human Psychopharmacology|September 21, 2004
The epidemiology of pain in depressionJean-Pierre Lépine, Mike Briley
Neuropsychiatric Disease and Treatment|July 14, 2011
The increasing burden of depressionJean-Pierre Lépine, Mike Briley
Human Psychopharmacology|June 7, 2008
Resolution of sexual dysfunction during acute treatment of major depression with milnacipranDavid Baldwin, Ricardo A Moreno, Mike Briley
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Current Opinion in Investigational Drugs (London, England : 2000)|May 22, 2002
The green evolution of psychotropic drugsMike Briley, Chantal Moret
Neuropsychiatric Disease and Treatment|July 14, 2011
The importance of norepinephrine in depressionChantal Moret, Mike Briley
Neuropsychiatric Disease and Treatment|July 14, 2011
The noradrenergic symptom cluster: clinical expression and neuropharmacologyPierre Blier, Mike Briley
Human Psychopharmacology|March 3, 2004
Sedation, an unpleasant, undesirable and potentially dangerous side-effect of many psychotropic drugsMichel Bourin, Mike Briley
Neuropsychiatric Disease and Treatment|July 14, 2011
Noradrenergic symptom cluster in depressionStuart Montgomery, Mike Briley
Human Psychopharmacology|May 30, 2009
Fibromyalgia: a complex syndrome requiring a multidisciplinary approachMichael Spaeth, Mike Briley
Human Psychopharmacology|May 30, 2009
Why psychiatrists should not ignore pain in their patients--focus on fibromyalgia?Stephen M Stahl, Mike Briley
Human Psychopharmacology|September 21, 2004
The epidemiology of pain in depressionJean-Pierre Lépine, Mike Briley
Neuropsychiatric Disease and Treatment|July 14, 2011
The increasing burden of depressionJean-Pierre Lépine, Mike Briley
Human Psychopharmacology|June 7, 2008
Resolution of sexual dysfunction during acute treatment of major depression with milnacipranDavid Baldwin, Ricardo A Moreno, Mike Briley
Pageof 3